CoChat

The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.

Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy

Open access

Abstract

While the use of creatine in human pregnancy is yet to be fully evaluated, its long-term use in healthy adults appears to be safe, and its well documented neuroprotective properties have recently been extended by demonstrations that creatine improves cognitive function in normal and elderly people, and motor skills in sleep-deprived subjects. Creatine has many actions likely to benefit the fetus and newborn, because pregnancy is a state of heightened metabolic activity, and the placenta is a key source of free radicals of oxygen and nitrogen. The multiple benefits of supplementary creatine arise from the fact that the creatine-phosphocreatine [PCr] system has physiologically important roles that include maintenance of intracellular ATP and acid-base balance, post-ischaemic recovery of protein synthesis, cerebral vasodilation, antioxidant actions, and stabilisation of lipid membranes. In the brain, creatine not only reduces lipid peroxidation and improves cerebral perfusion, its interaction with the benzodiazepine site of the GABAA receptor is likely to counteract the effects of glutamate excitotoxicity - actions that may protect the preterm and term fetal brain from the effects of birth hypoxia. In this review we discuss the development of creatine synthesis during fetal life, the transfer of creatine from mother to fetus, and propose that creatine supplementation during pregnancy may have benefits for the fetus and neonate whenever oxidative stress or feto-placental hypoxia arise, as in cases of fetal growth restriction, premature birth, or when parturition is delayed or complicated by oxygen deprivation of the newborn.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2393-14-150

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Creatine is an amino acid derivative involved with cellular energy production. In the form of energetically charged phosphocreatine (PCr), its primary function is to provide the phosphate group for regeneration of ATP from ADP in tissues of high and fluctuating energy demands. Human adults obtain approximately half of their daily requirement for creatine from a diet containing fresh fish, meat, and other animal products. The remainder is synthesized endogenously from arginine, glycine and methionine (methyl donor for GAMT reaction). This is a two-step process involving arginine:glycine aminotransferase (AGAT), principally in the kidney, producing guanidinoacetate (GAA), followed by hepatic guanidinoacetate methyltransferase (GAMT) activity producing creatine. Once synthesized, creatine is released from the liver into the circulation and taken up by most tissues, particularly muscle, by means of the creatine transporter. Inside the tissues a proportion of the creatine is phosphorylated to PCr, via the action of creatine kinase (CK). One important aspect of creatine biosynthesis is that the daily utilization of methyl groups on the GAMT reaction roughly equals the total daily intake of ‘labile’ methyl groups (methionine + choline) in an average diet. Thus, if methionine and choline levels are reduced, then endogenous creatine biosynthesis, responsible for half of our daily requirement for creatine, may be critically reduced.
Figure 1 Creatine is an amino acid derivative involved with cellular energy production. In the form of energetically charged phosphocreatine (PCr), its primary function is to provide the phosphate group for regeneration of ATP from ADP in tissues of high and fluctuating energy demands. Human adults obtain approximately half of their daily requirement for creatine from a diet containing fresh fish, meat, and other animal products. The remainder is synthesized endogenously from arginine, glycine and methionine (methyl donor for GAMT reaction). This is a two-step process involving arginine:glycine aminotransferase (AGAT), principally in the kidney, producing guanidinoacetate (GAA), followed by hepatic guanidinoacetate methyltransferase (GAMT) activity producing creatine. Once synthesized, creatine is released from the liver into the circulation and taken up by most tissues, particularly muscle, by means of the creatine transporter. Inside the tissues a proportion of the creatine is phosphorylated to PCr, via the action of creatine kinase (CK). One important aspect of creatine biosynthesis is that the daily utilization of methyl groups on the GAMT reaction roughly equals the total daily intake of ‘labile’ methyl groups (methionine + choline) in an average diet. Thus, if methionine and choline levels are reduced, then endogenous creatine biosynthesis, responsible for half of our daily requirement for creatine, may be critically reduced.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 137 references

Research works printed but not linked: 1

  1. Miller R, Davis BM, Brent RL, Koszalka TR: Transport of creatine in the human placenta. Pharmacologist. 1974, 16 (2): 305-

Cited by

See all 74

Metadata

Authors
Dickinson, H., Ellery, S., Ireland, Z., LaRosa, D., Snow, R., & Walker, D. W.
Affiliations
  • Hudson Institute of Medical Research (AU)
  • The University of Queensland (AU)
  • Deakin University (AU)
  • Monash Medical Centre (AU)
Corresponding author
Walker, David W
Venue
BMC Pregnancy and Childbirth
Published
2014-04-27
Volume
14
Issue
1
Pages
150-150
ISSN
1471-2393 (ISSN-L)
OpenAlex
W2048038395
Cited by
74
References
134
Citations by year
2026: 1 · 2025: 5 · 2024: 10 · 2023: 6 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 3 · 2017: 5 · 2016: 11 · 2015: 7 · 2014: 3
FWCI
1.39
Type
journal article
Language
en
Open access
Locations
  • BMC Pregnancy and Childbirth (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RMIT Research Repository (RMIT University Library) (submittedVersion)
  • Deakin Research Online (Deakin University) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
Monash University
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
creatine supplementation, pregnancy, oxidative stress, fetal growth restriction, preterm birth, neonatal hypoxia, GABAA receptor, glutamate excitotoxicity, lipid peroxidation, neuroprotection
MeSH terms
Creatine, Female, Fetal Hypoxia, Humans, Infant, Newborn, Pregnancy, Pregnancy Trimester, Third, Pregnancy, High-Risk, Dietary Supplements, Hypoxia-Ischemia, Brain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy. https://app.cochat.ai/papers/10.1186/1471-2393-14-150
The paper
Dickinson, H., Ellery, S., Ireland, Z., LaRosa, D., Snow, R., & Walker, D. W. (2014). Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy. BMC Pregnancy and Childbirth. https://doi.org/10.1186/1471-2393-14-150

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.